Lestaurtinib

Lestaurtinib

SCHEMBL16139562

C[C@@]12O[C@H](C[C@@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

FLT3JAK2NTRK1NTRK2NTRK3RET

The experimentally established mechanism targets of Lestaurtinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 known ✓ P04629 10/20 1.00
FLT3 known ✓ P36888 5/20 1.00
JAK2 known ✓ O60674 2/20 1.00
RET known ✓ P07949 2/20 1.00
NTRK3 known ✓ Q16288 1/20 1.00
NTRK2 known ✓ Q16620 1/20 1.00
KDR P35968 9/20 1.00
PRKCQ Q04759 7/20 1.00
PRKD3 O94806 5/20 1.00
PRKCA P17252 5/20 1.00
PRKCH P24723 5/20 1.00
PRKCI P41743 5/20 1.00
PRKCE Q02156 5/20 1.00
PRKCD Q05655 5/20 1.00
PRKD1 Q15139 5/20 1.00
MYLK Q15746 4/20 1.00
CDK4 P11802 3/20 1.00
CDK2 P24941 3/20 1.00
MAP3K11 Q16584 3/20 1.00
CAMKK2 Q96RR4 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lestaurtinib SCHEMBL730955 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL1649693 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL12228516 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL29625224 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL17971367 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL17971365 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL12963759 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL13169434 1.00 NTRK1 (1.00) NTRK1KDRPRKCQFLT3PRKD3
Lestaurtinib SCHEMBL30149252 0.99 NTRK1 (0.98) NTRK1KDRPRKCQFLT3PRKD3
SCHEMBL14342269 0.94 NTRK1 (0.89) NTRK1KDRPRKCQFLT3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220054499-A1 SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2022-02-24 US disclosed
US-11026952-B2 Small molecules for mouse satellite cell proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-06-08 US disclosed
US-20200352957-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2020-11-12 US disclosed
US-10660902-B2 Method of increasing satellite cell proliferation with an HDAC inhibitor PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-05-26 US disclosed
US-20180153902-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION HOWARD HUGHES MEDICAL INSTITUTE 2018-06-07 US disclosed
US-20180153902-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION HOWARD HUGHES MEDICAL INSTITUTE 2018-06-07 US disclosed
US-9248185-B2 Methods of increasing satellite cell proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-02-02 US disclosed
US-9248185-B2 Methods of increasing satellite cell proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-02-02 US disclosed
US-20140294855-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-10-02 US disclosed
US-20140294855-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11026952-B2 Small molecules for mouse satellite cell proliferation MKI67, MYLK2, MYH2 NTRK1 883/4885FLT3 3961/4885JAK2 4537/4885
US-10660902-B2 Method of increasing satellite cell proliferation with an HDAC inhibitor HDAC4, HDAC1, HDAC5 NTRK1 1901/4885FLT3 3951/4885JAK2 4579/4885
US-20220054499-A1 SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION MKI67, MYLK2, MYH2 NTRK1 883/4885FLT3 3961/4885JAK2 4537/4885
US-20180153902-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION MKI67, MYLK2, MYH2 NTRK1 1062/4885FLT3 4357/4885JAK2 4529/4885
US-20200352957-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION MKI67, MYLK2, MYH2 NTRK1 1062/4885FLT3 4357/4885JAK2 4529/4885
US-20140294855-A1 SMALL MOLECULE SCREENING FOR MOUSE SATELLITE CELL PROLIFERATION MKI67, MYLK2, MYH2 NTRK1 1123/4885FLT3 4382/4885JAK2 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.